Skip to main content

ACADIAN ASSET MANAGEMENT LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 916542 Boston, MA

Position in NBIX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$46,202,535
+$10,865,024 QoQ
Shares Held
350,710
+40.8% QoQ
Ownership
0.349%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $619,344,789 across 33 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (7.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
350,710 $46,202,535

All Filings in NBIX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $46,202,535 350,710
2025-12-31 $35,337,511 249,154
2025-09-30 $5,540,798 39,470
2025-06-30 $405,727 3,228
2025-03-31 $337,772 3,054
2024-12-31 $364,591 2,671
2024-09-30 $2,188,258 18,992
2024-06-30 $573,257 4,164
2024-03-31 $478,030 3,466
2023-12-31 $4,116,709 31,244
2023-09-30 $5,261,850 46,772
2023-06-30 $2,266,123 24,031
2023-03-31 $10,897,345 107,660
2022-12-31 $6,372,004 53,349
2022-09-30 $3,515,126 33,096
2022-03-31 $27,468 293
2021-06-30 $150,554 1,547
2021-03-31 $447,155 4,598
2020-12-31 $93,933 980
2020-09-30 $1,078,915 11,220
2020-06-30 $965,630 7,915
2020-03-31 $97,628 1,128